https://danielcameronmd.com/proposed-lyme-disease-guidelines-strike-out/

EDITORIAL: NEWLY PROPOSED LYME DISEASE GUIDELINES STRIKE OUT

In 2000, the Infectious Diseases Society of America (IDSA) published the first set of guidelines for the treatment of Lyme disease. The guidelines were criticized for not recognizing the existence and severity of chronic Lyme disease. The second set of guidelines, released by IDSA in 2006, again failed to recognize chronic Lyme disease. [1] Now, it would appear that the next set of soon-to-be-released guidelines are in danger of striking out again and not recognizing the existence and severity of chronic Lyme disease.

There is growing evidence supporting the existence and severity of chronic manifestations of Lyme disease. Studies have found that at least 1 in 3 patients treated for Lyme disease remained ill years after treatment. Furthermore, 4 clinical trials sponsored by the National Institutes of Medicine (NIH) documented the existence and severity of chronic manifestations of Lyme disease.[2-6]

Treating Lyme disease, whether it’s in the chronic or early stages of illness, can be complex and challenging. Many of the Lyme disease patients in the NIH trials remained ill for years, despite treatment. In fact, researchers reported that chronic Lyme disease patients’ quality of life “was equivalent to that of patients with congestive heart failure; pain levels were similar to those of post-surgical patients and fatigue was on par with that seen in multiple sclerosis,” according to the International Lyme and Associated Diseases Society’s (ILADS) 2014 evidence-based guidelines.

Meanwhile, studies from Johns Hopkins indicated that patients diagnosed with “post-treatment Lyme disease syndrome (PTLDS)” continued to be ill following antibiotic treatment, even though they received antibiotic therapy early on. PTLDS patients in the study suffered severe fatigue, pain, cognitive complaints, and poor function.

“Studies using rodent and primate models have suggested that the persistence of bacteria and/or spirochetal antigens after antibiotic therapy may drive disease,” explains Aucott from Johns Hopkins University School of Medicine.  

IDSA’s proposed Lyme disease guidelines dismiss psychiatric, behavioral and neurodevelopmental manifestations due to Lyme disease. CLICK TO TWEETThe IDSA guideline committee is again at-bat. This time, the committee included representatives from a broad range of other organizations in developing the guidelines. Their proposed Lyme disease guidelines have accepted the existence and severity of just one chronic manifestation of Lyme disease. That being, post-treatment Lyme arthritis.

“In patients who have failed one course of oral antibiotics and one course of IV antibiotics, we suggest a referral to a rheumatologist or other trained specialist for consideration of the use of disease-modifying anti-rheumatic drugs (DMARDs), biologic agents, intra-articular steroids, or arthroscopic synovectomy,” states the latest IDSA guidelines draft from August 2019.

Proving causality: Lyme disease and chronic manifestations

Unfortunately, the proposed guidelines do not accept the existence and severity of other chronic manifestations of Lyme disease, particularly those involving psychiatric, behavioral or neurodevelopmental manifestations. The committee dismissed these chronic manifestations of Lyme disease as not causal. As the authors state:

  • “No studies suggest a convincing causal association between Lyme disease and any specific psychiatric conditions.”
  • “There are no data to support a causal relationship between tick-borne infections and childhood developmental delay or behavioral disorders (such as attention deficit hyperactivity disorder, autistic spectrum disorders, Pediatric Autoimmune Neuropsychiatric Disorders Associated with Streptococcal Infections (PANDAS), learning disabilities, or psychiatric disorders).”

The committee’s argument is arguably similar to the debate on whether smoking causes lung cancer.  “At that time, the results of epidemiological studies had shown associations of smoking with increased risk for lung cancer and other cancers, for coronary heart disease, and for ‘emphysema’ and ‘bronchitis,’” writes Glass from Johns Hopkins University in the Annual Review of Public Health. [15]

The tobacco industry questioned the evidence. “Even as the epidemiological evidence mounted, the tobacco industry implemented a wide-ranging strategy to question the credibility of epidemiological evidence generally and of the most pivotal studies specifically,” writes Glass.

They created and spread doubt, as Glass explains, “The manufacture and dissemination of doubt remain strategies today, widely used by stakeholders whose interests are potentially threatened by a causal finding.”

The Infectious Diseases Society of America appears to be using the causality argument to question the evidence and manufacture and disseminate doubt.
If this draft is finalized, the committee is arguably about to strike out again for both doctors in clinical practice and their patients.

Editor’s note: Dr. Cameron is the first author for the 2004 and 2014 International Lyme and Associated Diseases Society (ILADS) guidelines that accepted the existence and severity of chronic Lyme disease.

It has become clearer that patients initially identified as having chronic Lyme disease suffer from a broad range of presentations including:

  1. Lyme encephalopathy [8]
  2. Lyme neuropathy [8]
  3. Neuropsychiatric Lyme disease [9]
  4. Pediatric neuropsychiatric disorders – PANS [10]
  5. Lyme carditis [11]
  6. Autonomic dysfunction – POTS [12]
  7. Post-treatment Lyme fatigue – Post-Lyme disease [6]
  8. Neuropathic pain [13]
  9. Persistent symptoms after Lyme disease [5]
  10. Lyme disease with co-infections (e.g. Babesia) [14]
References:
  1. Wormser GP, Dattwyler RJ, Shapiro ED, et al. The clinical assessment, treatment, and prevention of lyme disease, human granulocytic anaplasmosis, and babesiosis: clinical practice guidelines by the Infectious Diseases Society of America. Clin Infect Dis. 2006;43(9):1089-1134.
  2. Asch ES, Bujak DI, Weiss M, Peterson MG, Weinstein A. Lyme disease: an infectious and postinfectious syndrome. J Rheumatol, 21(3), 454-461 (1994).
  3. Shadick NA, Phillips CB, Logigian EL et al. The long-term clinical outcomes of Lyme disease. A population-based retrospective cohort study. Ann Intern Med, 121(8), 560-567 (1994).
  4. Fallon BA, Keilp JG, Corbera KM et al. A randomized, placebo-controlled trial of repeated IV antibiotic therapy for Lyme encephalopathy. Neurology, 70(13), 992-1003 (2008).
  5. Klempner MS, Hu LT, Evans J et al. Two controlled trials of antibiotic treatment in patients with persistent symptoms and a history of Lyme disease. N Engl J Med, 345(2), 85-92 (2001).
  6. Krupp LB, Hyman LG, Grimson R, et al. Study and treatment of post Lyme disease (STOP-LD): a randomized double masked clinical trial. Neurology. 2003;60(12):1923-1930.
  7. Rebman AW, Bechtold KT, Yang T, et al. The Clinical, Symptom, and Quality-of-Life Characterization of a Well-Defined Group of Patients with Posttreatment Lyme Disease Syndrome. Front Med (Lausanne). 2017;4:224.
  8. Logigian EL, Kaplan RF, Steere AC. Chronic neurologic manifestations of Lyme disease. N Engl J Med. 1990;323(21):1438-1444.
  9. Fallon BA, Nields JA. Lyme disease: a neuropsychiatric illness. Am J Psychiatry. 1994;151(11):1571-1583.
  10. Sigra S, Hesselmark E, Bejerot S. Treatment of PANDAS and PANS: a systematic review. Neurosci Biobehav Rev. 2018;86:51-65.
  11. Muehlenbachs A, Bollweg BC, Schulz TJ, et al. Cardiac Tropism of Borrelia burgdorferi: An Autopsy Study of Sudden Cardiac Death Associated with Lyme Carditis. Am J Pathol. 2016.
  12. Kanjwal K, Karabin B, Kanjwal Y, Grubb BP. Postural orthostatic tachycardia syndrome following Lyme disease. Cardiology journal. 2011;18(1):63-66.
  13. Simons LE. Fear of pain in children and adolescents with neuropathic pain and complex regional pain syndrome. Pain. 2016;157 Suppl 1:S90-97.
  14. Krause PJ, Telford SR, 3rd, Spielman A, et al. Concurrent Lyme disease and babesiosis. Evidence for increased severity and duration of illness. Jama. 1996;275(21):1657-1660.
  15. Thomas A. Glass, Steven N. Goodman, Miguel A. Hernán, and Jonathan M. Samet. Causal Inference in Public Health. Annu Rev Public Health. 2013; 34: 61–75.

https://www.lymedisease.org/lyme-disease-postage-stamp/

Bill would create postage stamp to help pay for more Lyme disease research

Dec. 6, 2019

https://articles.mercola.com/sites/articles/archive/2019/12/05/how-to-prevent-treat-seasonal-affective-disorder.aspx

How to Prevent and Treat Seasonal Affective Disorder

Analysis by Dr. Joseph MercolaFact Checked

STORY AT-A-GLANCE

  • Seasonal affective disorder (SAD) is a form of depression that occurs seasonally, typically ramping up in the fall and winter months and disappearing come spring
  • Helpful treatments include optimizing your vitamin D and omega-3 levels, light therapy (including blue light exposure in the morning, but not later in the day), optimizing your sleep, the Emotional Freedom Techniques and exercise
  • Your health and mood are intricately tied to exposure to sunlight. For example, your serotonin levels (the hormone typically associated with elevating your mood) rise when you’re exposed to bright light. Your melatonin level also rises and falls (inversely) with light and darkness
  • Vitamin D deficiency is very common, and should be a top consideration when you’re looking for a solution to flagging mood and energy — especially if it occurs during fall and winter months
  • While light therapy can take up to four weeks before you notice improvement, it was shown to be more effective than antidepressants for moderate to severe depression in a 2015 study

The loss of daylight hours during winter is a common cause of seasonal affective disorder (SAD), a type of depression that hits seasonally and lifts as spring and summer rolls back around.

The fact that SAD occurs when the days begin to darken and sunlight is at a minimum is not a coincidence. Your health and mood are intricately tied to exposure to sunlight. For example, your serotonin levels (the hormone typically associated with elevating your mood) rise when you’re exposed to bright light.

Your melatonin level also rises and falls — inversely — with light and darkness. When it’s dark, your melatonin levels increase, which is why you may feel tired when the sun starts to set, and in the heart of winter, this may be at as early as 3 p.m. if you live far from the equator. Light and darkness also control your biological clock, or circadian rhythm, which impacts hormones that regulate your appetite and metabolism.

As explained in the paper, “Seasonal Affective Disorder: An Overview of Assessment and Treatment Approaches,” published in the journal Depression Research and Treatment in 2015:1

“… SAD is a recurrent major depressive disorder with a seasonal pattern usually beginning in fall and continuing into winter months. A subsyndromal type of SAD, or S-SAD, is commonly known as ‘winter blues.’ Less often, SAD causes depression in the spring or early summer.

Symptoms center on sad mood and low energy. Those most at risk are female, are younger, live far from the equator, and have family histories of depression, bipolar disorder, or SAD … Typical treatment includes antidepressant medications, light therapy, vitamin D, and counselling.”

Considering the many health risks associated with antidepressants, and the fact that their efficacy is right on par with placebos, my recommendation is to avoid them if at all possible.

Aside from light therapy and vitamin D, other drug-free treatment options include optimizing your omega-3 level, exercise, the Emotional Freedom Techniques (EFT) and normalizing your circadian rhythm, all of which will be reviewed here.

The Role of Vitamin D

As explained in the featured paper,2 vitamin D appears to play a role in the activity of serotonin, a mood-balancing hormone, and melatonin, a hormone that responds to light and dark.

People with SAD tend to have lower serotonin and higher melatonin levels, which can account for the fatigue, tiredness and depressed mood typically associated with this condition. According to the Depression Research and Treatment paper:3

“A systematic review and meta-analysis concluded that low levels of vitamin D are associated with depression … During the winter months of November through February, those living about 33 degrees north or 30 degrees south of the equator are not able to synthesize vitamin D.

Many people with SAD and S-SAD have insufficient or deficient levels of vitamin D, and although no further studies have confirmed the findings, research investigating this association suggests that taking 100,000 IU daily may improve their symptoms.

Taking vitamin D before winter darkness sets in may help prevent symptoms of depression. Adverse reactions or intoxication is rare but could occur from doses of more than 50,000 IU per day.”

Vitamin D deficiency is very common, and should be a top consideration when you’re looking for a solution to flagging mood and energy — especially if it occurs during fall and winter months.

Ideally, you’ll want to get your vitamin D level tested twice a year, in summer and winter, when your levels are highest and lowest. This will help you fine-tune your dosage over time. While regular sun exposure is the best way to optimize your vitamin D level, this isn’t possible in many areas during the winter, thus necessitating the use of oral supplements instead.

GrassrootsHealth has a helpful calculator that can help estimate the dose required to reach healthy vitamin D levels based upon your measured starting point. The optimal level you’re looking for is between 60 and 80 ng/ml, and for all-around health, you’ll want to maintain this level year-round.

Omega-3 Fats Are Important Too

Another nutrient that can be helpful is marine-based omega-3. As noted in a 2009 review4 of three studies looking at the impact of omega-3 supplementation on patients with unipolar depression, childhood major depression and bipolar depression:

“Twelve bipolar outpatients with depressive symptoms were treated with 1.5-2.0 g/day of EPA for up to 6 months. In the adult unipolar depression study, highly significant benefits were found by week 3 of EPA treatment compared with placebo.

In the child study, an analysis … showed highly significant effects of omega-3 on each of the three rating scales. In the bipolar depression study, 8 of the 10 patients who completed at least one month of follow-up achieved a 50% or greater reduction in Hamilton depression scores within one month.”

In another study5 published that same year, people with lower blood levels of omega-3s were found to be more likely to have symptoms of depression and a more negative outlook while those with higher blood levels demonstrated the opposite emotional states.

A more recent review,6 published in 2015, pointed out that “Cell signaling and structure of the cell membrane are changed by omega-3-fatty acids, which demonstrates that an omega-3-fatty acid can act as an antidepressant.”

Importantly, this paper also points to research showing that the ratio of omega-3 to omega-6 is an important factor that can influence your depression risk. People with severe symptoms of depression have been found to have low concentrations of omega-3 in conjunction with considerably higher concentrations of omega-6.

You can learn more about the importance of this ratio in “Getting Your Omega-3 to Omega-6 ratio Right Is Essential For Optimal Health.” The key, really, to normalizing this ratio is to increase your omega-3 intake while simultaneously lowering your omega-6 consumption. This means you’ll need to ditch processed and fried foods, as they’re typically loaded with omega-6-rich vegetable oils.

Get Tested Today

GrassrootsHealth, which is conducting consumer-sponsored research into both vitamin D and omega-3, is one of your most cost-effective alternatives when it comes to testing.

Their vitamin D testing kit enrolls you into the GrassrootsHealth D*Action project, where your anonymized data will help researchers to provide accurate data about the vitamin D status in the population, the level at which disease prevention is obtained, and guidance on dosing to achieve optimal levels.

Their vitamin D, magnesium and omega-3 test kit is another option that will allow you to check the status of several vital nutrients at once. Each kit contains instructions for how to collect your blood sample. You then mail in your sample and fill out a quick online health questionnaire through GrassrootsHealth. A link to your test results will be emailed to you about a week after your blood samples have been received.

Light Therapy Is More Effective Than Antidepressants

Light therapy,7 using full-spectrum nonfluorescent lighting that has blue light to artificially mimic sunlight, is among the most effective treatment options for SAD. You want to avoid fluorescents as they emit large amounts of dirty electricity. Ideally, have the light exposure in the morning, well after sunrise. As noted in the Depression Research and Treatment paper:8

“Knowing the difference decreased daylight can make in triggering SAD and S-SAD, approaches seeking to replace the diminished sunshine using bright artificial light, particularly in the morning, have consistently showed promise …

Light boxes can be purchased that emit full spectrum light similar in composition to sunlight. Symptoms of SAD and S-SAD may be relieved by sitting in front of a light box first thing in the morning, from the early fall until spring …

Typically, light boxes filter out ultraviolet rays and require 20–60 minutes of exposure to 10,000 lux of cool-white… light daily during fall and winter.

This is about 20 times as great as ordinary indoor lighting … Light therapy should not be used in conjunction with photosensitizing medications such as lithium, melatonin, phenothiazine antipsychotics, and certain antibiotics.”

While light therapy can take up to four weeks before you notice an improvement, it was shown to be more effective than antidepressants for moderate to severe depression in a 2015 study.9,10 In it, the researchers evaluated the effectiveness of light therapy, alone and in conjunction with the antidepressant fluoxetine (sold under the brand name Prozac).

The eight-week trial included 122 adults between the ages of 19 and 60, who were diagnosed with moderate to severe depression. The participants were divided into four groups, receiving:

  • 30 minutes of light therapy per day upon waking, using a 10,000 lux Carex brand day-light device, classic model, plus a placebo pill
  • Prozac (20 mg/day) plus a deactivated ion generator serving as a placebo light device
  • Light therapy plus Prozac
  • Placebo light device plus placebo pill (control group)

In conclusion, the study found that the combination of light therapy and Prozac was the most effective — but light therapy-only came in at a close second, followed by placebo. In other words, the drug treatment was the least effective of all, including placebo.

The mean changes in the Montgomery-Åsberg Depression Rating Scale from baseline to the eight-week end point was 16.9 for the combination therapy (active light- and drug therapy), and 13.4 for light therapy alone.

Blue Light During Daytime Hours May Improve Your Mood

In addition to the bright white light used in light therapy, blue light has also been shown to be useful. According to a 2010 study,11 blue light appears to play a key role in your brain’s ability to process emotions, and its results suggest that spending more time in blue-enriched light could help prevent SAD.

Blue light is prevalent in outdoor light, so your body absorbs the most during the summer and much less in the winter. Because of this, the researchers suggested that adding blue light to indoor lighting, as opposed to the standard yellow lights typically used, may help boost mood and productivity year-round, and especially during the winter.

Keep in mind, however, that blue light after sunset or before sunrise should be avoided, as it can disrupt your circadian rhythm. In fact, one of the reasons for insomnia and poor sleep is related to excessive exposure to blue light-emitting technologies such as TV and computer screens, especially in the evening.

The blue light depresses melatonin production, thereby preventing you from feeling sleepy. So, to be clear, you only want to expose yourself to blue light in the morning, and possibly afternoon, but not in the evening.

In “How the Cycles of Light and Darkness Affect Your Health and Well-Being,” researcher Dan Pardi explains the peculiar effect blue light has on your brain, which sheds further light on why it’s so important to expose yourself to blue light during daytime hours only, and why you need to avoid it at night:

“[R]ods and cones in the eye… are specialized cells that can transduce a photo signal into a nerve signal… In the mid-90s, a different type of cell was discovered… [called] intrinsically photosensitive Retinal Ganglion Cells (ipRGC).

It does the same thing as rods and cones: it transduced light to a nerve signal. But instead of the signal going to your visual cortex, it goes to your master clock. Those cells are most responsive to blue light. If you can block blue light, you can actually create something called circadian darkness or virtual darkness.

What that means is that you can see, but your brain doesn’t think that it’s daytime; your brain thinks that it’s in darkness. That is actually a practical solution for living with artificial light in our modern world…

With more awareness, future digital devices will adjust lighting in the evening to automatically dim and emit amber/red light [instead of blue]. This is much better for healthy circadian rhythms and sleep quality.”

Address Insomnia

As you can tell by Pardi’s explanation above, the blue light issue is closely related to your sleep quality and circadian rhythm maintenance, and this too is an important component of mental health.

Historically, humans went to sleep shortly after sunset and woke up when the sun rose. Straying too far from this biological pattern will disrupt delicate hormonal cycles in your body, which can affect both your mood and your health. Indeed, the link between depression and lack of sleep is well established, and sleep disturbance is one of the telltale signs of depression.12

Sleep therapy has also been shown to significantly improve depression. While there are individual differences, as a general rule, you’ll want to aim for about eight hours of sleep per night.

For many, this will require going to bed earlier, which can be difficult if you’ve been watching TV or using electronics beforehand, as the blue light from the screen suppresses your melatonin production.

So, an important part of the solution is to avoid screen-time for a couple of hours before bed. Alternatives to not watching TV or using electronics is to install a blue light modulating software such as Iris,13 or using blue-blocking glasses.

Just make sure you don’t wear blue blocking glasses during the daytime, which is when you need the blue light exposure. Also, make sure the glasses filter out light between 460 to 490 nanometers (nm), which is the range of blue light that most effectively reduces melatonin. You can easily tell this by looking at a blue light and if it doesn’t disappear with the glasses, it is not blocking that frequency.

Exercise Helps Prevent Depression

Like sleep, exercise can impact your risk of depression. Even a minimal amount of exercise may be enough to combat depression in some people — as little as one hour a week could prevent 12% of future cases of depression, according to one study.14

Participants were followed for 11 years in this study, during which time it was revealed that people who engaged in regular leisure-time exercise for one hour a week, regardless of intensity, were less likely to become depressed. On the flipside, those who didn’t exercise were 44% more likely to become depressed compared to those who did so for at least one to two hours a week.

Exercise benefits your brain and mood via multiple mechanisms, including creating new, excitable neurons along with new neurons designed to release the GABA neurotransmitter, which inhibits excessive neuronal firing, helping to induce a natural state of calm15 — similar to the way anti-anxiety drugs work, except that the mood-boosting benefits of exercise occur both immediately after a workout and on in the long term.

Exercise also boosts levels of potent brain chemicals like serotonin, dopamine and norepinephrine, which may help buffer some of the effects of stress. What’s more, anandamide levels are known to increase during and following exercise.16 Anandamide is a neurotransmitter and endocannabinoid produced in your brain that temporarily blocks feelings of pain and depression. It can also be activated with CBD products.

Tap for Symptoms of Depression

Last but not least, EFT, a form of psychological acupressure, is a noninvasive way that can help treat symptoms of depression, whether related to seasonal light differences or not.

Some people avoid energy psychology, believing it’s an alternative form of New Age spirituality. Nothing could be further from the truth. It is merely an advanced tool that can effectively address some of the psychological short circuiting that occurs in emotional illnesses.

It is not associated with any religion or spiritual outlook at all, but merely an effective resource you can use with whatever spiritual belief you have. In the video above, EFT practitioner Julie Schiffman demonstrates how you can use EFT to relieve your symptoms.

It’s the Season To Be Glad, Not SAD

Since SAD is triggered by the loss of light, it makes sense that light therapy is among the most effective treatments. Vitamin D and/or omega-3 deficiency, as well as lack of sleep and exercise, can also play a significant role, so addressing these basic lifestyle factors could also be what you need to avoid the winter blues.

In closing, it may be worth noting that it’s natural for your body to want to slow down somewhat in the wintertime. While this can be difficult when your work and personal life dictate otherwise, allowing yourself to slow down a bit and surrender to the overwinter process may ultimately help you to respect your body’s circadian rhythm, and recharge.

That said, this doesn’t mean you should plant yourself on the couch for the winter and not venture outdoors. On the contrary, staying active and spending time outdoors during the day are among the best “cures” for SAD.

– Sources and References

https://www.bca-clinic.de/en/the-link-between-lyme-disease-and-dementia/

The Link Between Lyme Disease and Dementia

Lyme disease results from infection with the bacterium Borrelia burgdorferi, which is transmitted to humans through the bite of some ticks. Common early symptoms of the illness include fever, headache, fatigue and a characteristic red rash (erythema migrans) at the site of the tick bite.

Early diagnosis is crucial. The sooner Lyme disease is recognised, the easier it is to cure fully with a course of oral antibiotics. As the infection progresses, it may become a lot more persistent. If left untreated for a long time, Lyme disease may enter a chronic phase. The infection can spread throughout the body and cause serious joint, heart and neurological symptoms.

Since the erythema migrans rash is absent in 20–30% of patients and the other symptoms can mimic other illnesses, Lyme disease is often difficult to diagnose. The available laboratory tests are also unreliable in the early stages of the illness. Therefore, doctors have to consider factors such as the patient’s history of tick bites and recent visits to high-risk areas, in addition to any physical signs and symptoms, when making a diagnosis.

Lyme Disease and the Brain

Some common questions about Lyme disease and the brain are ‘Can Lyme disease cause dementia-like symptoms?’ and ‘Does Lyme disease cause memory problems?’ To answer these, let’s take a look at the stats.

Lyme disease leads to profound effects on the brain in about 15% of cases. Some sources suggest that this proportion may be even higher, since thousands of cases are believed to remain undiagnosed every year. A small percentage of patients continue to experience neurological symptoms after receiving timely antibiotic treatment for Lyme disease. This phenomenon is often referred to as ‘post-treatment Lyme disease syndrome’, and its possible cause is a widespread inflammation of the brain.

Neurological Symptoms of Lyme Disease

Chronic Lyme disease develops when the infection remains unrecognised and untreated for a long time. In patients with strong immune systems, the initial symptoms can be very mild and may even go unnoticed. The bacteria can live inside the cells and not cause any problems for several months or even years.

Serious symptoms of chronic Lyme disease tend to first appear when immune function becomes disrupted due to another illness, stress or environmental factors. This is when the bacteria begin to proliferate at a greater pace, and travel to various different tissues and organs.

When Lyme disease becomes chronic and the bacteria spread to the brain, the resulting condition is referred to as neuroborreliosis. Common neurological and psychological symptoms of neuroborreliosis are cognitive decline, memory impairment, mood swings, decreased energy levels, difficulty concentrating, sleep disturbances, disrupted fine motor control and vision changes.

In rare cases, neuropsychiatric Lyme disease can cause paranoia, hallucinations, mania and obsessive-compulsive symptoms. In children, the most common symptoms of neuroborreliosis are headaches, behavioral changes, learning difficulties and sleep disorders.

Patients with chronic Lyme disease often report extreme fatigue. They can sleep for as many as 10 to 12 hours, yet not feel rested after waking up. Increased sensitivity to light and loud sounds can also develop.

Diagnosing Neurological Lyme Disease

In addition to serological testing, patients with suspected neuroborreliosis may benefit from a brain MRI scan. The scan may reveal lesions similar to those caused by multiple sclerosis. Spine lesions have also been observed in some cases. Other diagnostic methods to consider are nerve conduction studies and neurocognitive tests.

Secondary Dementia Due to Lyme Neuroborreliosis

Severe dementia resulting from neuroborreliosis is extremely rare. However, dementia-like syndromes associated with Lyme disease have been reported on occasion.

In a few cases, the condition has seemed to trigger primary dementia, such as Alzheimer’s disease. Persistent chronic Lyme disease is normally treated with several courses of intravenous antibiotics, but it’s unclear whether serious neuropsychiatric symptoms are completely reversible.

Lyme Disease and Dementia/Alzheimer’s Disease

The dementia and other signs of cognitive decline caused by severe neuroborreliosis tend to resemble the symptoms of Alzheimer’s disease. Some research studies have indicated the presence of Borrelia burgdorferi in the brains of Alzheimer’s patients, suggesting a possible link between the two conditions. While Lyme disease can be successfully cured with antibiotics in most cases, the exact causes of Alzheimer’s disease remain unknown, and no effective treatment currently exists.

So how does Lyme affect you in old age? Well, one 2014 study aimed to determine if there was an actual relationship between Lyme and Alzheimer’s. The scientists collected data from the US Centers for Disease Control and Prevention on the incidence of Lyme disease and deaths associated with Alzheimer’s disease. They then analysed the information in search of any significant correlations.

One of the findings of the study was that the 13 states with the highest prevalence of Lyme disease actually had the lowest number of deaths from Alzheimer’s disease. Moreover, the seven states with the highest incidence rates of Alzheimer’s were among the 13 states with the fewest number of Lyme disease cases. Vermont was the only state reporting a high incidence of both conditions. Any other potential associations were found to be statistically insignificant.

The link between Lyme disease and dementia remains unclear, but considering the other possible implications of contracting chronic Lyme, it’s better to be safe than sorry and protect yourself against tick bites altogether.

________________________

For more:  https://madisonarealymesupportgroup.com/2017/06/10/the-coming-pandemic-of-lyme-dementia/

https://madisonarealymesupportgroup.com/2019/05/30/why-lyme-disease-is-causing-a-mental-health-crisis/

https://madisonarealymesupportgroup.com/2019/06/22/dementia-from-illness/

https://madisonarealymesupportgroup.com/2019/03/10/baseballs-tom-seaver-diagnosed-with-dementia/

https://madisonarealymesupportgroup.com/2018/03/25/a-brief-history-of-neuroborreliosis-research-dementia-an-inside-look-at-two-researchers/

https://madisonarealymesupportgroup.com/2016/06/03/borrelia-hiding-in-worms-causing-chronic-brain-diseases/

Don’t forget our support group meeting this Saturday!

Details: https://madisonarealymesupportgroup.com/2019/11/20/december-2019-support-group-meeting/